Renin-Angiotensin-Aldosterone System Blockade in Diabetes: Role of Direct Renin Inhibitors

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

(2013) Regina Kunz et al.   ANNALS OF INTERNAL MEDICINE

Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study

(2008) Steven A. Yarows et al.   ADVANCES IN THERAPY

Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes

(2008) Xinhua Yan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis

(2008) Steven G. Chrysant et al.   CURRENT MEDICAL RESEARCH AND OPINION

Economic Costs of Diabetes in the U.S. in 2007

(2008)   DIABETES CARE

Prorenin and (pro)renin receptor: a review of available data fromin vitrostudies and experimental models in rodents

(2008) Geneviève Nguyen et al.   EXPERIMENTAL PHYSIOLOGY

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats

(2008) David L. Feldman et al.   HYPERTENSION

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes

(2008) F. Persson et al.   KIDNEY INTERNATIONAL

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

(2008) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE